Ads
related to: abbvie pharmaceuticals stock- AbbVie News Center
See Our Achievements, Growth Story,
and More Today.
- Read AbbVie Stories
Read Stories About Our Science,
People, and More Today.
- Investor Resources
Find Financial Reports, Stock Info
And More Resources For Investors.
- Supporting Our Workforce
Embracing Equality & Diversity
Makes Us More Innovative.
- AbbVie News Center
Search results
Zacks Research Weighs in on AbbVie Inc.’s FY2024 Earnings (NYSE:ABBV)
ETF DAILY NEWS· 9 hours agoAbbVie Inc. (NYSE:ABBV – Free Report) – Research analysts at Zacks Research raised their FY2024 EPS estimates for AbbVie in a note issued to investors on ...
Investors Heavily Search AbbVie Inc. (ABBV): Here is What You Need to Know
Zacks· 3 days agoFree Report) is one of the stocks most watched by Zacks.com visitors lately. The Zacks Large Cap Pharmaceuticals industry, to which AbbVie belongs, has ...
3 Magnificent Stocks That Are Passive Income Machines
Motley Fool via Yahoo Finance· 3 days agoBut that's because of how much the stock has gained recently. The dividend itself hasn't lagged...
What Is the Dividend Payout for AbbVie Stock?
Motley Fool via Yahoo Finance· 4 days agoMany investors hold a stake in AbbVie (NYSE: ABBV) because it offers exposure to the healthcare sector. Industry-based diversification, however, isn't...
AbbVie (ABBV) Boosts Neuropsychiatric Portfolio With New Deal
Zacks via Yahoo Finance· 3 days agoThe transaction is expected to close in mid-2024, subject to shareholder and regulatory approval....
AbbVie shares hold Buy rating with $180 target from TD Cowen By Investing.com
Investing.com· 3 days agoOn Tuesday, TD (TSX:TD) Cowen maintained a positive stance on AbbVie Inc . TD Cowen adjusted its...
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 7 days agoIronwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Q1 2024 Earnings Call Transcript May 9, 2024 Ironwood ...
Are You Looking for a High-Growth Dividend Stock?
Zacks via Yahoo Finance· 21 hours agoDividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does AbbVie (ABBV) have what it takes?...
AbbVie Inc. (NYSE:ABBV) Receives $174.31 Average Target Price from Brokerages
ETF DAILY NEWS· 5 days agoThree research analysts have rated the stock with a hold recommendation and ten have issued a buy recommendation on the company. The average 12-month target price among analysts ...
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever.
The Motley Fool via AOL· 6 days agoOver time, that's potentially 10% to 11% of total returns, which can quickly build wealth for...
Ad
related to: abbvie pharmaceuticals stock